Cigna Group $CI Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC lessened its stake in Cigna Group (NYSE:CI) by 2.0% in the 2nd quarter, Holdings Channel reports. The firm owned 106,809 shares of the health services provider’s stock after selling 2,212 shares during the period. Corient Private Wealth LLC’s holdings in Cigna Group were worth $35,310,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC acquired a new stake in shares of Cigna Group in the first quarter valued at $28,000. 1248 Management LLC purchased a new position in Cigna Group during the 1st quarter valued at about $29,000. Solstein Capital LLC acquired a new stake in shares of Cigna Group during the second quarter worth about $29,000. Chilton Capital Management LLC acquired a new stake in shares of Cigna Group during the second quarter worth about $30,000. Finally, Activest Wealth Management boosted its stake in shares of Cigna Group by 360.0% in the first quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 72 shares during the period. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CI has been the topic of several recent research reports. JPMorgan Chase & Co. cut their target price on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 4th. Morgan Stanley restated an “overweight” rating and issued a $355.00 price target on shares of Cigna Group in a research note on Friday, October 31st. Jefferies Financial Group reiterated a “buy” rating and issued a $310.00 price objective on shares of Cigna Group in a research note on Monday, November 3rd. Deutsche Bank Aktiengesellschaft decreased their target price on Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a report on Monday, November 3rd. Finally, Sanford C. Bernstein cut their price target on Cigna Group from $346.00 to $294.00 and set a “market perform” rating on the stock in a report on Wednesday, November 12th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and a consensus target price of $331.83.

Insider Activity at Cigna Group

In related news, CEO David Cordani bought 4,134 shares of the stock in a transaction dated Monday, November 3rd. The stock was acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares in the company, valued at approximately $38,201,317.80. This represents a 2.69% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Stock Performance

Shares of CI stock opened at $276.12 on Wednesday. The company has a market cap of $73.76 billion, a P/E ratio of 12.18, a PEG ratio of 1.01 and a beta of 0.26. The firm has a fifty day moving average price of $279.29 and a 200 day moving average price of $293.37. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. The company had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.Cigna Group’s quarterly revenue was up 9.5% on a year-over-year basis. During the same period last year, the firm earned $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio is 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.